Key points are not available for this paper at this time.
Design
Review
This review highlights the molecular and clinical implications of white adipose tissue heterogeneity, emphasizing that central obesity carries higher cardiometabolic risk than peripheral obesity.
Adipose tissue is a highly heterogeneous endocrine organ. The heterogeneity among different anatomical depots stems from their intrinsic differences in cellular and physiological properties, including developmental origin, adipogenic and proliferative capacity, glucose and lipid metabolism, insulin sensitivity, hormonal control, thermogenic ability and vascularization. Additional factors that influence adipose tissue heterogeneity are genetic predisposition, environment, gender and age. Under obese condition, these depot-specific differences translate into specific fat distribution patterns, which are closely associated with differential cardiometabolic risks. For instance, individuals with central obesity are more susceptible to developing diabetes and cardiovascular complications, whereas those with peripheral obesity are more metabolically healthy. This review summarizes the clinical and mechanistic evidence for the depot-specific differences that give rise to different metabolic consequences, and provides therapeutic insights for targeted treatment of obesity.
No takes yet. Share an insight, caveat, or question.
Kwok et al. (2016) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: